Clinical Trial Update: Study to Assess the Safety and Efficacy of CD-NP in the Treatment of Patients With Acute Decompensated Heart Failure [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on the safety and efficacy of CD-NP for acute decompensated heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Heart Failure

Drugs mentioned

• CD-NP (CD-NP)

Snippet

Sponsor: Nile Therapeutics | Conditions: Acute Decompensated Heart Failure | Phase 2 | Status: COMPLETED